PNC Financial Services Group
RANI icon

PNC Financial Services Group’s Rani Therapeutics RANI Stock Holding History

PNC Financial Services Group’s Portfolio RANI Stock Details RANI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-2,000
Closed -$1.03K – 5211
2025
Q2 		$1.03K Hold
2,000
– – ﹤0.01% 4558
2025
Q1 		$2.52K Hold
2,000
– – ﹤0.01% 4283
2024
Q4 		$2.74K Hold
2,000
– – ﹤0.01% 4207
2024
Q3 		$4.32K Hold
2,000
– – ﹤0.01% 4082
2024
Q2 		$7.6K Sell
2,000
-7,116
-78% -$36.9K ﹤0.01% 3864
2024
Q1 		$28.4K Hold
9,116
– – ﹤0.01% 3265
2023
Q4 		$30.3K Buy
9,116
+1,700
+23% +$3.93K ﹤0.01% 3215
2023
Q3 		$16.1K Hold
7,416
– – ﹤0.01% 3539
2023
Q2 		$30.6K Hold
7,416
– – ﹤0.01% 3331
2023
Q1 		$38.3K Hold
7,416
– – ﹤0.01% 3128
2022
Q4 		$43.8K Hold
7,416
– – ﹤0.01% 3060
2022
Q3 		$71K Hold
7,416
– – ﹤0.01% 2764
2022
Q2 		$77K Buy
7,416
+7,116
+2,372% +$81.7K ﹤0.01% 2747
2022
Q1 		$4K Hold
300
– – ﹤0.01% 4067
2021
Q4 		$5K Buy
+300
New +$6.82K ﹤0.01% 3984

Other funds holding RANI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NFGH
Nan Fung Group Holdings Kai Tak, Hong Kong $121M AUM 56.89% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
USAA
United Services Automobile Association San Antonio, Texas $851M AUM 5.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
KPWS
Kestra Private Wealth Services Austin, Texas $8.11B AUM 24.74% 1-Year Est. Return
TPC
Takeda Pharmaceutical Company Tokyo, Japan $16.4M AUM 195.92% 1-Year Est. Return
CAMG
CWA Asset Management Group Naples, Florida $3.28B AUM 34.07% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

PNC Financial Services Group's RANI Position: Q3 2025 in Review

PNC Financial Services Group sold out of Rani Therapeutics (RANI) in Q3 2025, closing a stake of 2,000 shares — an estimated $1.03K sold.

PNC Financial Services Group first reported a position in RANI in Q4 2021 and held it in 15 quarters. The position peaked at $77K in Q2 2022. 38 funds tracked by Wall St. Rank hold RANI as of Q3 2025.

  • PNC Financial Services Group reported no remaining Rani Therapeutics position as of Q3 2025 after selling out during the quarter.
  • PNC Financial Services Group sold 2,000 Rani Therapeutics shares in Q3 2025, an estimated $1.03K.
  • PNC Financial Services Group first reported a position in Rani Therapeutics in Q4 2021 and held it in 15 quarters.
  • PNC Financial Services Group's Rani Therapeutics position peaked at $77K in Q2 2022.
  • 38 funds tracked by Wall St. Rank held Rani Therapeutics as of Q3 2025.

Based on PNC Financial Services Group's 13F filing for Q3 2025, filed 7 Nov 2025.